Table 2. Neutralization antibody assay of porcine-derived AAVs and published AAVs against homologous or heterologous antisera and pooled human IgG.
Vector | ||||||||
---|---|---|---|---|---|---|---|---|
*Anti-sera | AAVpo2.1 | AAVpo4 | AAVpo5 | AAVpo6 | AAV5 | AAV1 | AAV6 | AAV8 |
AAVpo1 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 |
AAVpo2.1 | 1:320 | <1:20 | <1:20 | 1:40 | <1:20 | <1:20 | <1:20 | <1:20 |
AAVpo4 | <1:20 | 1:640 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 |
AAVpo5 | <1:20 | <1:20 | 1:40 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 |
AAVpo6 | <1:20 | <1:20 | <1:20 | 1:640 | <1:20 | <1:20 | <1:20 | <1:20 |
AAV5 | <1:20 | <1:20 | <1:20 | <1:20 | 1:5120 | n/a | n/a | n/a |
**Pooled Human IgG (mg/mL) | >12 | >12 | >12 | 1.5 | 0.1875 | n/a | n/a | n/a |
*Values represent dilution of anti-sera required to neutralize >50% of AAV-LacZ transducing particles.
**Values represent concentration of antibody in mg/mL, required to neutralize >50% of AAV-LacZ transducing particles.